We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Helena Laboratories

Helena Laboratories is a clinical laboratory instrument and reagent manufacturer with a product range comprising elec... read more Featured Products: More products

Download Mobile App




Simplified Microchip Electrophoresis Rapidly Separates Urinary Proteins

By LabMedica International staff writers
Posted on 27 Mar 2014
Print article
Image: Conventional Agarose Gel Electrophoresis for proteins (Photo courtesy of Helena).
Image: Conventional Agarose Gel Electrophoresis for proteins (Photo courtesy of Helena).
A urine protein test is to detect the presence of protein in a person's urine, while in healthy individuals, there is only very low concentration of protein in urine, but in renal patients, the concentration of urine protein will increase considerably.

Urine protein test has been widely used in clinics, but to determine the type of proteinuria is usually difficult due to technical limitations. A rapid and simple method to separate and determine urine proteins by a microchip electrophoresis (ME) system has been developed which can be completed rapidly.

Scientists at the Affiliated Hospital of Nantong University (Jiangsu Province, China) developed quick and straightforward method to separate urine proteins with ME. By testing different experimental conditions, the optimal parameters were established and the duration of the analytical run takes less than four minutes. They compared ME and conventional agarose gel electrophoresis (AGE) and by analyzing 248 urine samples.

The chip electrophoresis apparatus consisted of an optical module, a control module, and a detection module (Shanghai Institute of Microsystem and Information Technology; China). The 214 nm UV light was obtained by a hologram grating and focused the separation channel to detect the presence of protein. The light absorbed by a sample was gathered by a photomultiplier tube (Hamamatsu; Beijing, China) and converted to electric signals, which were then processed by a filtering and amplifying circuit and input to a computer.

The patient group contained 178 urine samples, of which no protein peak was detected for 7 samples, 60 were selective proteinuria with primary protein of albumin, 105 were nonselective proteinuria with various molecular weight proteins, and 6 were overflow proteinuria. The same results were obtained by conventional AGE (Helena; Beaumont, TX, USA) as the ME.

The authors concluded that the assay was rapid, simple, and convenient, with electrophoretic time only four minutes with good reproducibility. The electrophoresis apparatus and detection system were cheap and microfluidic chip could be repeated. The newly established ME provided a useful clinical tool with broad potential applications for the diagnosis, treatment, and prognosis of renal and related diseases. The study was published in the March 2014 issue of the Journal of Clinical Laboratory Analysis.

Affiliated Hospital of Nantong University
Shanghai Institute of Microsystem and Information Technology
Helena 

Related Links:
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.